Andreas Stahl

Research Bio

Andreas Stahl is the Ruth Okey Chair and Professor in the Metabolic Biology and Nutrition. The overarching goal of the Stahl laboratory is to advance human health by engineering solutions for obesity-related disorders such as Type-2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). To this end, Dr. Stahl is investigating molecular mechanisms governing lipid uptake, particularly for fatty acids and CoQ, mitochondrial function, hepatobiliary diseases, and adipocyte biology. He has been pioneering investigations into the role of biomechanical forces in brown adipose tissue (BAT) activation and is working on novel lipid nanoparticle-based approaches to expand and activate BAT. Further, Dr. Stahl’s lab is developing New Approach Methodologies (NAM) based on human induced pluripotent stem cell derived microphysiological systems, aka organ-on-a-chip devices, particularly for the functional interrogation of the fat-liver axis. The lab’s current focus with these NAMs is to facilitate the assessment of biological mechanisms, such as aging, and diseases, including T2DM and MASLD, as well as testing of pharmacological intervention strategies, in the context of human relevant preclinical models.

Dr. Stahl is a member of QB3-Berkeley and the UC Berkeley-UCSF Graduate Program in Bioengineering as well as the Chair of the Metabolic Biology Graduate Program. At Berkeley, he teaches and mentors students in metabolic biology and its connections to human diseases.

Research Expertise and Interest

metabolism, obesity, adipose tissue, brown fat, thermogenesis, diabetes, fatty acid transport, fatty acid, stem cells, microphysiological systems, lipid nanoparticles, liver disease

In the News

Smelling your food makes you fat

Our sense of smell is key to the enjoyment of food, so it may be no surprise that in experiments at the University of California, Berkeley, obese mice who lost their sense of smell also lost weight.
Loading Class list ...